Institutional Ownership
Neurocrine Biosciences Inc
CUSIP 64125C109COMNBIXQ1 2026
13D / 13G Filings
32
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
13.9%
Max % of class reported
Institutional Holders
682
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
32 filings · latest Jan 21, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 21, 2026 | Jpmorgan Chase &Amp; Co. | 13G | 5.2% | 5.20M | SEC |
| 2 | May 14, 2025 | Dodge &Amp; Cox | 13G | 5.6% | 5.53M | SEC |
| 3 | Apr 28, 2025 | Blackrock, Inc. | 13G/A | 12.1% | 12.05M | SEC |
| 4 | Mar 6, 2025 | The Vanguard Group | 13G/A | 10.2% | 10.13M | SEC |
| 5 | Feb 5, 2025 | State Street Corporation | 13G | 4.8% | 4.89M | SEC |
| 6 | Oct 17, 2024 | State Street Corp | 13G | 5.1% | 5.15M | SEC |
| 7 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.9% | 9.71M | SEC |
| 8 | Jan 23, 2024 | Blackrock Inc. | 13G/A | 13.9% | 13.65M | SEC |
| 9 | Feb 9, 2023 | Janus Henderson Group PLC | 13G/A | 2.5% | 2.42M | SEC |
| 10 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 9.7% | 9.34M | SEC |
22 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Neurocrine Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 13.39M | $1.76B |
| 2 | Dodge & Cox | 5.46M | $719.44M |
| 3 | Jpmorgan Chase & Co | 5.44M | $700.50M |
| 4 | Aqr Capital Management LLC | 4.94M | $650.66M |
| 5 | State Street Corp | 4.35M | $573.67M |
| 6 | Two Sigma Investments, LP | 3.06M | $403.20M |
| 7 | Renaissance Technologies LLC | 2.42M | $318.67M |
| 8 | Geode Capital Management, LLC | 2.14M | $280.80M |
| 9 | Bnp Paribas Asset Management Holding S.A. | 1.49M | $196.77M |
| 10 | Wellington Management Group LLP | 1.39M | $183.06M |